Detailansicht

Wissensnetz

Person

Daniel Gotthardt (1973-)

Arzt

Name	Daniel Gotthardt
Zeit	1973- (Lebensdaten)
Ort	Heidelberg (Wirkungsort) Deutschland
Geschlecht	männlich
Akademischer Grad bzw. Titel	Prof. Dr. med.
Beruf	Arzt (charakteristischer Beruf)
Variante	Daniel Nils Gotthardt Daniel Gotthardt Daniel N. Gotthardt D. N. Gotthardt
Beziehung	Universitätsklinikum Heidelberg (seit 2004)
Weitere Angaben	Diss. Medizinische Fakultät; Geschäftsführender Oberarzt der Medizinischen Klinik IV Sektionsleiter Lebertransplantation, Medizinische Klinik, Universitätsklinikum Heidelberg
Datensatztyp	Person
GND-Nummer	12903293X
Datensatz-ID	12903293X
Beteiligt an alle anzeigen Comparative proteomics reveals different protein expression in platelets in patients with alcoholic liver cirrhosis The macrophage activation marker soluble CD163 is elevated and associated with liver disease phenotype in patients with Wilson’s disease Association between serum IgG level and clinical course in primary sclerosing cholangitis Prevalence of human herpesviruses in biliary fluid and their association with biliary complications after liver transplantation Long-term evaluation of urinary copper excretion and non-caeruloplasmin associated copper in Wilson disease patients under medical treatment Genetic variants in PNPLA3 and TM6SF2 predispose to the development of hepatocellular carcinoma in individuals with alcohol-related cirrhosis Survival of Hepatocellular Carcinoma Patients Treated with Sorafenib beyond Progression Secretion of Hepatitis C virus replication intermediates reduces activation of Toll-like receptor 3 in hepatocytes Comparative assessment of clinical rating scales in Wilson’s disease Carcinoembryonic Antigen Level in Primary Sclerosing Cholangitis Is Not Influenced by Dominant Strictures or Bacterial Cholangitis Location of a biliary leak after liver resection determines success of endoscopic treatment Empfehlungen zur antiviralen Therapie der chronischen Hepatitis C bei Patienten auf der Warteliste und nach Transplantation Impact of neo-adjuvant Sorafenib treatment on liver transplantation in HCC patients - a prospective, randomized, double-blind, phase III trial Outcomes and risk factors for cancer patients undergoing endoscopic intervention of malignant biliary obstruction Risk factors and outcome in patients with primary sclerosing cholangitis with persistent biliary candidiasis Criteria used in clinical practice to guide immunosuppressive treatment in patients with primary sclerosing cholangitis Criteria Used in Clinical Practice to Guide Immunosuppressive Treatment in Patients with Primary Sclerosing Cholangitis Risk factors and outcome in patients with primary sclerosing cholangitis with persistent biliary candidiasis Effect of delayed CNI-based immunosuppression with Advagraf® on liver function after MELD-based liver transplantation [IMUTECT] Bacteriobilia and fungibilia are associated with outcome in patients with endoscopic treatment of biliary complications after liver transplantation Alterations of lipid metabolism in Wilson disease Myocardial late gadolinium enhancement cardiovascular magnetic resonance in patients with cirrhosis Budd-Chiari Syndrome: Long term success via hepatic decompression using transjugular intrahepatic porto-systemic shunt Therapie benigner Gallengangsstenosen nach Lebertransplantation Untersuchung der Phagozytose in dem Modellorganismus Dictyostelium discoideum

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Daniel Gotthardt (1973-)

Comparative proteomics reveals different protein expression in platelets in patients with alcoholic liver cirrhosis

The macrophage activation marker soluble CD163 is elevated and associated with liver disease phenotype in patients with Wilson’s disease

Association between serum IgG level and clinical course in primary sclerosing cholangitis

Prevalence of human herpesviruses in biliary fluid and their association with biliary complications after liver transplantation

Long-term evaluation of urinary copper excretion and non-caeruloplasmin associated copper in Wilson disease patients under medical treatment

Genetic variants in PNPLA3 and TM6SF2 predispose to the development of hepatocellular carcinoma in individuals with alcohol-related cirrhosis

Survival of Hepatocellular Carcinoma Patients Treated with Sorafenib beyond Progression

Secretion of Hepatitis C virus replication intermediates reduces activation of Toll-like receptor 3 in hepatocytes

Comparative assessment of clinical rating scales in Wilson’s disease

Carcinoembryonic Antigen Level in Primary Sclerosing Cholangitis Is Not Influenced by Dominant Strictures or Bacterial Cholangitis

Location of a biliary leak after liver resection determines success of endoscopic treatment

Empfehlungen zur antiviralen Therapie der chronischen Hepatitis C bei Patienten auf der Warteliste und nach Transplantation

Impact of neo-adjuvant Sorafenib treatment on liver transplantation in HCC patients - a prospective, randomized, double-blind, phase III trial

Outcomes and risk factors for cancer patients undergoing endoscopic intervention of malignant biliary obstruction

Risk factors and outcome in patients with primary sclerosing cholangitis with persistent biliary candidiasis

Criteria used in clinical practice to guide immunosuppressive treatment in patients with primary sclerosing cholangitis

Criteria Used in Clinical Practice to Guide Immunosuppressive Treatment in Patients with Primary Sclerosing Cholangitis

Risk factors and outcome in patients with primary sclerosing cholangitis with persistent biliary candidiasis

Effect of delayed CNI-based immunosuppression with Advagraf® on liver function after MELD-based liver transplantation [IMUTECT]

Bacteriobilia and fungibilia are associated with outcome in patients with endoscopic treatment of biliary complications after liver transplantation

Alterations of lipid metabolism in Wilson disease

Myocardial late gadolinium enhancement cardiovascular magnetic resonance in patients with cirrhosis

Budd-Chiari Syndrome: Long term success via hepatic decompression using transjugular intrahepatic porto-systemic shunt

Therapie benigner Gallengangsstenosen nach Lebertransplantation

Untersuchung der Phagozytose in dem Modellorganismus Dictyostelium discoideum